Find a Pharmacy
Vertice Login
Menu
close
Info banner
A significant part of the Healthesystems vision is to create a more integrated experience for our customers

Advocacy & Compliance

Healthesystems’ Advocacy & Compliance experts are essential in the management of pharmacy and ancillary benefits for our clients. By tracking and influencing regulatory activity, our team stays  ahead of evolving trends and identifies opportunities to advocate on behalf of our clients, their injured workers, and the broader industry.

The Advocacy & 
Compliance Team

Monitors and reports on proposed and pending regulatory changes that impact workers' comp, helping shape effective program strategies

Advocates for fair and balanced public policy through proactive engagement with regulators, customers, and other stakeholders throughout the rulemaking lifecycle

Supports operational compliance by providing guidance to internal stakeholders and external partners during the implementation of new regulatory changes

Regulatory Recap

A weekly e-newsletter informed by the Advocacy & Compliance team to help keep our clients and industry contacts in the know on the latest legislation and policy updates impacting workers’ comp.
Subscribe

California Publishes Independent Medical Review Report

Pharmaceutical requests represented 30.6% of all treatment requests submitted for IMR, a modest decline from 32.7% in 2024.
Read More →
May 25, 2026

Georgia Enacts Regulations for Psychedelic Clinics

The Georgia Composite Medical Board will issue rules and regulations for clinics administering psychedelic-assisted therapies by December 31, 2026.
Read More →
May 25, 2026

Colorado Could Expand Cancer Coverage for Firefighters

Senate Bill 184 passed both chambers and now sits with Governor Polis.
Read More →
May 25, 2026

WCRI Publishes Interstate Variation and Trends Report on Drug Payments

Dermatological agents remained a significant cost driver, in part due to physician dispensing and delivery pharmacies, which accounted for a significant number of high-cost transactions.
Read More →
May 25, 2026

Montana Proposes Updates to Formulary and Fee Schedule, Requesting Stakeholder Feedback

A remote hearing will be held on May 28th, with comments accepted through June 5th. If enacted, changes will take effect July 1st.
Read More →
May 18, 2026

Oklahoma Enacts Law for Ibogaine Clinical Trials

Effective November 1st, the Department of Health can enter into contracts with drug developers to conduct ibogaine clinical trials.
Read More →
May 18, 2026

Connecticut Could Soon Expand Psychedelic Pilot Program

Previously limited to veterans and other specific populations, the bill could apply to any adult that meets clinical eligibility criteria.
Read More →
May 18, 2026

Louisiana Considers Psychedelic-Assisted Therapy Program

Psilocybin and ibogaine clinical trials would target opioid use disorder and treatment-resistant mental health conditions.
Read More →
May 18, 2026

Minnesota Considers Psychedelics Therapy Program

A three-year pilot program would allow for 1,000 patients annually to receive treatment for PTSD, depression, chronic pain, and more.
Read More →
May 18, 2026
1 2 3 4 … 54

Subscribe to Regulatory Recap

Get weekly legislation & policy updates straight to your inbox.
regulatory recap newsletter image
hello world!

 Further resources you may be interested in

Additional articles and updates from Healthesystems related to policy shaping workers’ comp.

Pennsylvania Proposes Reimbursement Caps for Compounds and Topicals

The bill would create a $400, 30-day supply cap for compound drugs.
Read More

New Jersey Proposes Marijuana Reimbursement in Workers’ Comp and Group Health

Companion bills S3984 and A1023 would require health insurance coverage for the medical use of cannabis under certain circumstances.
Read More

Florida Appeals Court Rules in Favor of Carriers and Employers on Physician-Dispensed Drugs

While injured workers have an absolute choice over their pharmacist, physicians are not considered pharmacists and therefore not entitled to reimbursement.
Read More

WCRI Publishes National Repository on Prescription Drug Regulations

While the report addresses multiple topics, a significant focus was given to the expanding role of pharmacists as a healthcare provider.
Read More

Expert Q&A: What Utah’s AI Prescription Renewal Pilot Signals About the Evolving Role of AI in Treatment Decisions

Utah’s prescription renewal pilot is a groundbreaking use case for AI in healthcare. What are the potential benefits and pitfalls?
Read More

Inside Medical Experience: Signals, Trends, and System Impact

Healthe’s VP of Industry and State Affairs, Sandy Shtab, joins a panel presentation at the Pennsylvania/Delawaare 2026 Workers’ Compensation Symposium.
Read More
1 2 3 4 … 51
Back to Top
lockmap-markermagnifiercrossmenuarrow-rightcross-circle